Infertility affects a large share of couples worldwide, and in roughly half of those cases, a male factor is involved — yet male reproductive health has historically taken a back seat in fertility workups. A new study published in The Lancet Obstetrics, Gynaecology, & Women's Health is changing that conversation by simultaneously analyzing the vaginal, intestinal, and seminal microbiomes and linking them to real reproductive outcomes.

The standout finding: a distinct microbial imbalance in semen — dubbed "seminal V-dysbiosis" — was associated with a dramatically lower chance of live birth and a higher risk of pregnancy loss, both in IVF patients and couples with recurrent pregnancy loss. Experts say this underscores the need to evaluate fertility as a couple's issue, not just a female one.

By the Numbers

• 57% live birth rate in IVF couples where the male had seminal V-dysbiosis
• 85% live birth rate in IVF couples where the male did not have this pattern
• ~50% of infertile couples have an associated male factor
• 30–40% of men with abnormal semen have no identifiable cause (idiopathic male infertility)

Why it matters: While the findings are observational and not yet practice-changing, they open a compelling new frontier. If future trials show that correcting seminal dysbiosis improves outcomes, it could reshape how clinicians approach unexplained infertility — one of the field's most stubborn challenges.